To date no mature evidence supports routine adoption of immunotherapy. »
05/11/20

Enzalutamide reduced the hazard of death by 17%. »
11/08/19

Higher RT dose not associated with improved clinical outcomes. »
10/16/19

miRNA-486-5p could induce apoptosis and inhibit cell migration ability of cells. »
12/12/19

Simulation with CCL18 and simultaneous inhibition of cyclooxygenase in MCF-7 resulted in increased ERK activation. »
03/08/20

Roles of probiotics in modulating and reducing gastrointestinal adverse effects caused by cervical cancer therapies. »
03/16/20

Co-expression of TRF2 and VEGF-A correlate with poor clinical outcome in stage I-III colorectal cancer patients. »
06/15/20

Recurrence rate among patients who had 131-iodine ablation with 1.1 GBq not higher than with 3.7 GBq. »
06/15/20

Decreased risk of PCa observed for men with T2DM. »
06/15/20

Survival difference exceeding 15 years observed. »
06/16/20